Repligen Corp
RGEN· Nasdaq
RGENRepligen Corp
Filed May 10, 2012 · 10-Q · 40 days after period end · 0001193125-12-224145
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $12.82M | $5.91M |
| Net Income | $1.23M | -$2.03M |
| EPS Diluted | $0.04 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Repligen Corp · CIK 730272 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 10, 2012 · 40 d after period end
